[Guidelines for stage I to III melanoma]

Bull Cancer. 2016 Sep;103(9):743-52. doi: 10.1016/j.bulcan.2016.06.002. Epub 2016 Jul 22.
[Article in French]
No abstract available

Publication types

  • Practice Guideline

MeSH terms

  • Antineoplastic Agents / therapeutic use
  • Chemotherapy, Adjuvant
  • Female
  • Genotype
  • Humans
  • Male
  • Margins of Excision
  • Melanoma / classification
  • Melanoma / diagnosis
  • Melanoma / pathology
  • Melanoma / therapy*
  • Neoplasm Staging
  • Proto-Oncogene Proteins B-raf / genetics
  • Sentinel Lymph Node / pathology
  • Sentinel Lymph Node Biopsy
  • Skin Neoplasms / classification
  • Skin Neoplasms / diagnosis
  • Skin Neoplasms / pathology
  • Skin Neoplasms / therapy*

Substances

  • Antineoplastic Agents
  • BRAF protein, human
  • Proto-Oncogene Proteins B-raf